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This project aimed to aid legislators by presenting quantitative evidence on what policies
existing literature supports as working in dealing with the problem of heroin use in order
to shift policies to a more effective approach. Chi Square analysis of 100 quantitative
studies revealed that there is a relationship between the type of approach and outcome of
the study, indicating that maintenance-focused approaches are more likely to work than
the other approaches examined. The study concluded that, while the literature finds
consensus on the idea that “maintenance works”, the details of implementation cause
disagreement between fields; overall, maintenance works for those who want it to work
and policy makers should focus on implementing broad legislation where the details of
policy can be worked out based on each community’s unique situation, the demand for
services, and in seeking to use resources in the most effective and efficient manner.
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Introduction
Few topics incite such an emotionally strong reaction as does heroin. In today’s
society, it has become synonymous with abuse, destruction, and even death, and no one is
immune from its effects on individuals and society as a whole. Not only have national
and international directives sought to place heightened importance on prevention of the
destruction in peoples’ lives caused by heroin, but policymakers have faced increasing
pressure from their constituencies to solve the problem of heroin. But what exactly is the
problem of heroin? It is the quadruped rate of heroin related overdose deaths from 2002
to 2013 and the 18,893 overdose deaths related to prescription pain relievers and 10,574
related to heroin in 2014 (Narconon). It is the 586,000 Americans 12 or older who had a
substance use disorder involving heroin and the 23% of individuals who use heroin and
develop opioid addiction. It is the 900% increase in the amount of heroin confiscated in
Cincinnati between 2010 and 2011, the similar trend in Chicago’s suburbs, and in central
Michigan, as well as small rural Kentucky and West Virginian towns where as many as 9,
14, 26, and even 50 individuals have overdosed over the course of a few hours in “mass
heroin overdoses” (Narconon, Kocher). It is an epidemic worthy of the designation.
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This problem has a solution. In fact, the problem has many proposed solutions.
As these solutions have been tried and evaluated, a large body of literature has focused on
heroin policy and effectiveness of approaches based on each approach’s unique goals.
Over time, heroin use and abuse has been approached through many lenses, of crime,
health, medicine, legal, and economic, among others. With so many conflicting
approaches, policymakers have, to date, been limited in their ability to implement
effective legislation because, although some approaches were seen as more effective than
others, the many interests of the many groups involved conflicted, hindering the
realization of the approaches into practice. The current prevalence of heroin use and
damaging consequences of addiction have acted as a call to action for policy makers,
however, making them, and society, painfully aware of the lack of implementation of
effective policy to date.
This project aimed to aid legislators by presenting quantitative evidence on what
policies existing literature supports as working in dealing with the problem of heroin use
in order to shift policies to a more effective approach. As a secondary objective, it sought
to address why, in the face of a seemingly present consensus within literature, policy is
not being implemented. To gauge the presence of a consensus in existing literature, the
study used a meta-analysis approach through the review and coding of 100 quantitative
outcome evaluations of heroin abuse treatment programs or techniques. Additionally,
examination of methods used over time in dealing with addiction and the presence of goal
conflict, groupthink, and misalignment between fields offers a probable explanation for
the difficulties legislators face in reaching a policy consensus.
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Exploring and Explaining the Heroin Epidemic
While this analysis aims to divulge the consensus of existing literature regarding
the most effective approach in dealing with the problem of heroin use and addiction,
knowing what research says is only half the battle. Taking that consensus and applying it
to the situation is often the more difficult step, and it has proven to be so in the heroin
epidemic as well. While there seems to be a general literary consensus, even among and
between fields, very little is being done to implement the policies that have been shown
to work. This prompts the questions, “What are the reasons for this consensus?” and
“Why, despite the consensus, is so little being done to apply it?” To begin addressing
these questions, it is helpful to explore what is already known about the heroin epidemic,
both historically and currently, and to understand the different fields involved, the way
those fields define and approach aspects of heroin addiction, and the issues plaguing the
policy-making process that can influence the implementation of policy in response to the
heroin epidemic. Therein, as will be seen, lies the possible explanation for the lacking
implementation.

Heroin in a Historical Context
Despite the present state of the heroin epidemic, one could easily believe that it is
a uniquely American concern that has skyrocketed in social prevalence as of late. While
the latter is true, with the Obama administration making clear that addressing the
epidemic is of the upmost priority at the National Rx Drug Abuse and Heroin Summit in

5
Early 2016 (White House Office of the Press Secretary, 2016), heroin has been an issue
of universal, rather than exclusively American, concern since the 1800’s and even before.
Heroin as a drug has its roots in the long history of opioids, which are derived
from opium, the poppy plant. In Mesopotamia in the 3400’s B.C, opium use began. It
then expanded from Egypt and Persia to Europe, India, and China, and then to the United
States in the 1700’s as a therapeutic agent, though users and physicians alike eventually
noted opium’s addictive qualities. In 1805, morphine was derived from opium as a pain
reliever, and because physicians believed that the addictive qualities of opium had been
tamed with the derivation of morphine, which was lauded as being reliable, long lasting,
and safe, opium and morphine dependence and addiction increased. This abuse, however,
was not recreational; rather it stemmed from the physicians’ ignorance to the destructive
qualities of the drugs, leading to over-use and addiction. In 1874, heroin was synthesized
for the first time, from morphine by C.R. Wright in England, but it was not produced
commercially until 1895 when Heinrich Dreser diluted morphine with acetyls producing
the same heroin (or diacetylmorphine) at Bayer Pharmaceuticals. Bayer advertised
heroin as non-addictive and it was also used as a replacement opioid, but this time for
morphine.
Heroin was the penultimate of a series of drugs developed from opium that were
hoped to, by being purer and stronger, be less addictive than the prior drug. Additionally,
in combination with the hypodermic needle, recreational use of the drugs for a high
became possible during the 19th century. As each new drug was introduced, touting less
destructive side effects, the previous was not only replaced, but also censured. For
example, after the introduction of morphine and later heroin, Britain passed the Opium
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Act in 1878 with hopes of reducing opium consumption by restricting the use to
registered Chinese opium smokers and Indian opium eaters, while San Francisco banned
smoking opium in the city limits.
While it is important to understand the origins of heroin as a drug, this study
focuses on the perceptions and responses to heroin use and addiction, so understanding
the societal response alongside the history of the drug is imperative. Beginning in the
1800’s in the United Kingdom, recovery and temperance were key solutions to addiction
and dependence, as seen in the way each new, “safer” opium derivative was used to
replace the prior, as the prior was condemned and access to it was restricted. This was the
case, as mentioned, with morphine, and then again in 1898 when heroin was introduced
as a substitution for morphine. Additionally, much like the drug use itself, the issue as a
whole was seen through a medical lens. This medical lens approached addiction as an
issue that needed “treatment”, though treatment varied in scope and practice (Berridge
2012; Mold 2004). Most often, the treatment was replacing one opioid with another;
even in the United States in 1900, the St. James Society began sending heroin to
morphine addicts in order to help them quit. Though the social issues associated with
addiction were acknowledged during this time, they were not addressed with as much
vigor as treating the addiction itself (Mold 2004).
As time progressed, however, “curing” became the buzz word over “treatment”
and emphasis was placed on true abstinence (Berridge 2012). Physicians had begun
discussing the side effects of using heroin as a step-down cure for morphine and, in a
series of scholarly articles, many physicians came to the conclusion that the same
withdrawal symptoms and detrimental effects of addiction were present, regardless of the
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use of heroin or morphine, and that “treatment” was no longer effective, switching the
end-goal to a complete curing of the addiction. In 1906, Alexander Lambert and Charles
Towns began advocating for their cure for the addiction- a seven-day regimen including a
five-day purge of the drug from the addicts’ body. These individuals were greatly
involved in drug legislation in the United States, in the early 1900’s, which highlights, in
a way, the general approach taken by the United States in contrast to that taken in the
United Kingdom.
In the United States, the approach included prohibitive legislation, a generalized
approach to the entire problem of opioid use, and initiating an increasingly penal era of
drug policy; in the United Kingdom, the approach was more centered on the individual
addicts with treatment (Berridge 2012). Of course, there were elements of both
approaches throughout, as seen in Lambert and Towns’ “cure” in the United States and
legislation passed in the United Kingdom to limit opium use, but generally, the two
countries approached the issue of heroin and opioid addiction in dissimilar ways. The
discrepancy between the two countries may have its roots in the origins of the countries’
battles with eradicating opioids, heroin, and the associated addiction. The United States
took a tough-on-drugs approach through legislative action and politically charged
campaigns, bypassing the addicts as a point of action in favor of law enforcement and
legislation.

Because of this, the United States got caught up in the language and details

of combatting addiction and the heroin epidemic, making reaching a policy consensus
impossible since the many groups involved had different goals, definitions, and thought
processes. England’s roots of approaching addiction medically and with treatment for the
individuals affected by addiction, however, allowed them to focus on the addiction itself
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and find a solution through supportive, rather than restrictive, legislation that got at the
root of the problem- the addicts. Overall, the culprit seems to have been federalism and
separation of powers in the United States versus a unitary parliamentary government in
England. Because this was happening in the Progressive Era, when federal authority was
generally expanding, the issue was dealt with federally rather than by the states, meaning
the governments’ systems were influential on the way the countries progressed in dealing
with the heroin epidemic.
With the focus on prohibitive legislation in the United States, the early 1900’s
saw much legislative action, including the U.S. Congress’s Pure Food and Drug Act,
which required that medicines have contents labeling and reduced the availability and
consumption of opiates, and the county’s first federal drug prohibition in 1909, which
outlawed the import of opium. This ban was in preparation for the Shanghai Conference,
which aimed to address the ongoing problem of opioid trade between India, China, and
western Europe. At the conference, the U.S. encouraged suppressing the sale of opium to
China and, headed by Dr. Hamilton Wright and Episcopal Bishop Henry Brent, the
American delegation attempted to convince the rest of the international delegates of the
detrimental effects of opium. In 1914, the Harrison Narcotics Act was passed, which
required physicians register and pay a tax to prescribe narcotics, and in 1919, the League
of Nations met, where American legislators pressed for international restrictions on drugs
and trafficking. In 1922, the Narcotics Import and Export Act was passed, which
restricted the importation of opium with the exception of medical use, and 1923 saw the
U.S. Treasury Department’s Narcotic’s Division ban all legal narcotics sales, forcing the
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sale and use of heroin to addicts and the streets. Finally, in 1924, the Heroin Act made
the manufacture and possession of heroin illegal.
With the onslaught of legislation through the 1910’s and 20’s, addiction began to
be redefined as a social disease, especially in America, away from one experienced on the
individual level. In this transition, the two spheres- social and individual- were distinct in
dealing with the problem; the health of addicts was of medical concern while the social
problems were addressed by law enforcement and the penal system (Mold 2004). This
separation was a root of much contradiction and confusion in the early days of heroin
policy. In the United Kingdom, 1926 saw the introduction of the Rolleston Report,
which advocated the idea that medicine needed to be involved in treating the addiction,
shifting the focus of addiction back from crime to disease and sparking the “British
System” of maintenance and liberal pragmatism (Berridge 2012; Mold 2004; Seddon,
Ralphs, and Williams 2008). Within this era, the Atlantic separated the two main
approaches toward heroin policy, with America maintaining supply- and demandreduction through penal measures and Europe, and especially Britain, emphasizing harmreduction and treatment of the addiction. The 1920’s, then, set the tone for the next 40
years of drug and addiction policy and, as the decades progressed, there was an emphasis
on locating the disease within society. To do this, surveillance and government
intervention were increased, and, combined with approaching the issue with a public
health motivation, merging of the medical and social aspects of drug addiction began
(Berridge 2012, Mold 2004).
The 1960’s and 70’s saw drastic changes to drug policy in America. U.S.
involvement in Vietnam was blamed for the surge in smuggled heroin, and the number of
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addicts reached over 750,000. While Britain and other European countries had been
treating addiction as a medical issue with heroin maintenance treatment for years and
would continue to do so even into the present (Uchtenhagen 2011), harm reduction and
maintenance treatment were being introduced for the first time in America as pioneered
by Vincint Dole and Marie Nyswander in 1963 (Berridge 2012; Latowsky 2006;
Uchtenhagen 2011). This maintenance approach did not use heroin, however, because it
was still stigmatized as an illicit drug; rather, methadone was the substitution drug of
choice because it was viewed as a medical intervention, in contrast to the fear of enabling
addicts that would occur with using heroin itself as the maintenance drug (Berridge
2012). While morphine was the original substitute for street heroin in the U.S., it was
abolished as a substitution due to the continuing prohibitive attitude toward drugs that
plagued American policy during this time; morphine would be viewed similarly to how
heroin as a substitute would be viewed, as enabling the addict by giving them illicit
substances (Uchtenhagen 2011). In 1970, the Controlled Substance Act was passed,
which categorized drugs, and mandated regulations and penalties for use. Maintenance
treatments struggled continuously, and still do, with the stigma attached to drug use and
the popular view of addiction as criminal behavior. While America was taking the first
steps toward harm-reduction during this time, the “British System” was engaged in a
nuanced shift-in-focus from long-term maintenance with minimum dose prescribing to
short-term Methadone maintenance with abstinence and recovery as the ultimate goal
(Berridge 2012).
The 1980’s became characterized by a universally increased focus on reducing the
harm from drugs within the context of America’s “War on Drugs”, which many now
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claim as being overly punitive, expensive, and ineffective (Berridge 2012; Reuter 2013).
In America, drug use had peaked in the 1970’s and, after tracking specific epidemics, the
focus was on eradicating the heroin problem (Compton et al. 2005). Within the
increasingly punitive approach, which aimed at reducing the supply of and demand for
heroin, conflict arose as advocates of harm reduction strategies attempted to work toward
a new public health imperative- preventing the transmission of HIV/AIDS (Berridge
2012). There was a renewed hierarchy of objectives in America, with a shift from shortterm maintenance with the goal of abstinence to long-term maintenance and needleexchange programs to improve public health (Berridge 2012; Seddon, Ralphs, and
Williams 2008). Maintenance programs eventually became a cornerstone for prevention
of HIV/AIDS and managing dependence to reduce harm for the addicted individuals and
the community as a whole (Uchtenhagen 2011). This approach, however, became
controversial in the United States due to its conflict with the traditional supply- and
demand-reduction approaches. Treatment and public health approaches were able to gain
legitimacy through the “brain disease model”, however, wherein the United States
National Institute on Drug Abuse introduced addiction as a chronic, relapsing brain
disorder in need of pharmaceutical interventions (Berridge 2012). Because of this
science-based justification, harm-reduction approaches were able to gain support and the
controversy was somewhat mitigated.
With this newly introduced view of addiction, the 1990’s began a transition to the
idea that “Treatment Works” in a variety of objectives, including keeping addicts out of
prison, which was of growing concern as the criminal justice system began to feel the
stresses of increased punitiveness over the last few decades. With this realization,
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maintenance and methadone were revived alongside public health initiatives. Within this
newly user-focused movement, a shift from the community-focused public health
movement of years before, prescribing was seen as a central strategy for combatting the
problem (Berridge 2012). Over the past two decades, maintenance has been advocated as
important not just for harm-reduction overall, but specifically in preventing the
transmission of diseases like HIV and AIDS (Latowsky 2006) and more research is being
done on its effectiveness.
With the success of methadone as maintenance treatment, Levacetylmethadol
(LAAM) was approved in 1993 for licensed narcotic treatment programs and the FDA
granted exclusive authority for dispensing methadone and LAAM for treatment, though
with many regulatory hurdles (Rawson et al. 1998). In 2002, buprenorphine was
approved as an additional opioid agonist due to its advantages over methadone, such as
less stigma, lower overdose rates, and less regulation, and in 2010, naltrexone was
approved in a new injectable form, which improved adherence rates and blocked the
reinforcing effects of heroin with no opioid-like effects (Gordon, Kinlock, and Miller
2012).
In the more recent past, a ten-year review of the 1998 UN General Assembly
Special Session’s goal of reducing drug production and consumption concluded that no
prevention, treatment, or enforcement strategies that have been tried have been effective
and that, at this point, the goal should be to reduce the damaging consequences of supplyand demand- reduction strategies and, instead, focus on other harm-reduction based
avenues of dealing with the problem (Reuter 2009). While a solution has not been found
through the volatile course of policy in the past 200 years, with a constant tug of war

13
between supply- and demand- reduction and harm-reduction approaches, a policy
consensus would undoubtedly help in addressing heroin as an issue. As history seems to
indicate, however, maintenance approaches have survived the test of time and, while they
have evolved and changed since being used initially, show many benefits in addressing
heroin addiction as well as the public health issues that arise from it.

Understanding the Approaches
A large part of understanding not only the history of heroin policy, but also its
current state and the future of addressing the ever-expanding heroin epidemic, lies in the
language used by proponents of different policy perspectives and the definitions adhered
to by professionals in each of many related fields in regard to the potential approaches.
After delineating the two main spheres of policy, more nuanced positions within the
approaches will be explained, as will be the different focuses of policy related to each
approach and how the chosen emphasis of different approaches serves to classify studies
in this meta-analysis.
To begin, when dealing with the problem of heroin, there are two main spheres.
Within these spheres are more fine-tuned approaches. The first sphere is that of supply
and demand reduction, which focuses on reducing either the amount of the drug available
(supply reduction) or the demand for that drug (demand reduction), typically through
regulation or prohibition (Greenfield and Paoli 2012). Typically, this approach is
punitive in nature, and has been historically advocated for by the criminal justice system
and those adhering to a crime-control model of thinking. Under this thought process,
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controlling crime and criminals in the main goal of policy, with proponents accentuating
the big picture of reducing crime to protect and better society through enforcing laws and
maintaining social order, as opposed to the protection of individuals. Supply and demand
reduction, as a unified crime-control-centered approach, is known to cause unintended
consequences and have extra costs due to the focus on aggressive use of the criminal
justice system and quick procedural administration of justice. Because of this, the
approach leads to a paradox in that the goal is to improve the societal situation by
reducing production and consumption, but the adverse consequences often lead to no
aggregate change in the supply of the drug (Greenfield and Paoli 2012).
The second sphere is that of harm reduction, which has a less than clear
definition. Rather than a definitive designation, harm reduction is more of a goal, which
purposes to reduce harm associated with the use of the drug without necessarily reducing
drug consumption itself. Reducing use is a principle, but not sole, means of reducing
harm (Greenfield and Paoli 2012). The International Harm Reduction Association
defines harm reduction broadly as, “policies, programs, and practices that aim primarily
to reduce the adverse health, social and economic consequences of the use of legal and
illegal psychoactive drugs without necessarily reducing drug consumption”.
Additionally, harm reduction cuts across the spectrum from safer use to managed use,
and then further to abstinence. The approach aims to meet the addicted individual where
they are without condemning their behaviors, and instead to work with them and the
community as a whole to minimize the harmful effects of drug use and the individuals’
behaviors (Marlatt and Witkiewitz 2010).

15
When looking at both supply and demand reduction and harm reduction, there is
often a juxtaposition of the approaches and of those who adhere to each school of
thought. Opponents of harm reduction tend to fear that reducing the harmfulness of the
drug use will increase use, while opponents of use reduction fear reducing use of the
drugs will increase the harmfulness of the drug use. It has come to be understood,
however, that both approaches have a role in dealing with any epidemic, including those
of drugs like heroin, but each approach has strengths and weaknesses that must be
considered in implementation, and they must ultimately be used at different times and
when most appropriate and beneficial, rather than being advocated as being universally
beneficial (Caulkins, Tragler, and Wallner 2009).
Within harm reduction strategies, there are two main avenues: one dealing with
the community and the other dealing with the individual. In dealing with the community
is the public health approach, where community-based programs such as needleexchanges, public education opportunities, and support groups are implemented to
educate the community as a whole about harms and issues associated with heroin use and
the effects of the epidemic, as well as to reduce some of the more immediate public
harms, such as transmission of communicable diseases with needle exchange programs.
The public health approach centers its strategy of reducing harm within the context of the
community, placing less focus on the addicts themselves.
The other avenue within harm reduction is treatment, which focusses on the
addicted individual and how to treat their addiction, as if it is a sickness or disease
(Gelkopf, Levitt, and Bleich 2002), but also with the intention of educating the addicts
and encouraging responsible use and personal accountability for their addiction
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(Koutroiulis 2000). Sometimes, abstinence is the ultimate goal of treatment, but within
the treatment aspect of harm reduction is the notion that harm can be reduced without
necessitating that users stop their drug use, which is, while less ambitious, more
achievable than an ultimate objective of abstinence (Koutroulis 2000).
My meta-analysis focuses on treatment approaches, distinguishing between
maintenance and all other treatment approaches, which often encompass abstinence as the
primary treatment goal whether the method be rehabilitation, detoxification, behavioral
and cognitive therapies, or forced withdrawal. Abstinence, as a treatment approach,
focuses on the addiction with the end goal of ending the addiction through whatever
means necessary. On the other hand, maintenance approaches focus on survival and
allowing the addicted individuals to proceed as more-or-less functioning members of
society while reducing the harm associated with their use. Under maintenance, abstinence
or beating the addiction is a secondary goal of treatment, with emphasis placed on the
health and survival of the addict.
To understand the goal of maintenance treatments, it is important to understand
the alternative- withdrawing. The process for withdrawing from opioids like heroin is so
torturous that most individuals cannot physically or emotionally bear it, leading to
relapse. Individuals feel as though they are dying and, in a sense, they are, because their
bodies are unable to function without the presence of the drug in their systems. Addicts
are dependent on the drug to function and live, so maintenance treatments, which focus
on survival, allow individuals to maintain their normal level of functioning in society,
maintaining their quality of life by managing the addiction with drugs that are safer, more
controlled, administered clinically, and ultimately can be reduced slowly, over time,
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under the supervision of professionals, and with less withdrawal symptoms. In this way,
maintenance treatments offer the benefit of being a way to achieve long-term abstinence,
but in a way that is not as emotionally, mentally, or physically damaging, and in a way
that is more manageable and sustainable as to prevent relapse.
Within maintenance treatments, there are a multitude of specific approaches,
utilizing different drugs, dosages, time frames, maintenance schedules, administration
procedures, environments, requirements of the addicts, and costs. Exploring each of
these is beyond the scope of this meta-analysis, mainly because maintenance as a broad
approach works, and the lack of implementation lies the smaller details of specific
maintenance treatments, on which policy makers and professionals cannot agree. This
study, as will be explained in more detail later, does not discriminate between the details
of maintenance treatments. Instead, it simply classifies the studies as either maintenance
or not maintenance, based on the treatment approach used. Because of this, the study is
unable to discern between maintenance approaches nor is it able to evaluate the efficacy
among them.

Policy and Problems
With an understanding of the history of heroin and the language associated with
strategies of combatting the epidemic, it is apparent that there is still much to be done in
regards to research on the topic. While heroin itself is not a new problem, the prevalence
of the problem is, and historically appropriate approaches are no longer so. The
consensus of the literature, as will be confirmed by this meta-analysis, is that under the
umbrella of harm-reduction strategies, treatment options, and more specifically
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maintenance treatments, are effective in dealing with the heroin problem based on a
variety of goals for “effectiveness”. With that consensus, the main concern lies in why
these policies and strategies are not being implemented. This leads to the question of
why, in the face of mounting evidence in favor of maintenance treatment approaches to
heroin, there is a lack of policy consensus and implementation. This project takes steps
to answer this question, first by quantitatively analyzing literature to identify a potential
consensus, and then by exploring potential reasons for the lack of implementation seen in
practice.

Methods
This project was a meta-analysis of quantitative studies regarding approaches to
heroin addiction and abuse. The goal of this analysis was to aid legislators by presenting
quantitative evidence on what policies work best in dealing with the problem of heroin
use so that this knowledge can be used to shift policies to a more effective approach. The
procedures for conducting this analysis can be described as follows: 1, determine the
inclusion criteria for studies; 2, identify and select studies; 3, review and coding of
studies; 4, Chi-Square analysis of coded results.
1. Inclusion Criteria
Without access to software programs used in most meta-analyses that screen
abstracts from large databases, and without the man-power that can be used to
supplement and review the work of abstract screening software, I was severely limited in
my study selection. Because of these limitations, my data collection was done
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completely by hand. At the beginning of the project, I determined a simple set of
inclusion criteria that I would use to determine the eligibility of studies. This criteria,
however, was modified and refined as the project continued.
Eligible studies were determined to be quantitative outcome evaluations of heroin
abuse treatment programs or specific techniques. The original set of inclusion criteria
mandated random-controlled trials and either pre-test-post-test or treatment-comparison
designs, however this criterion was determined to be too stringent considering the severe
ethical limitations in dealing with special populations, as many of the studies did.
Additionally, my inclusion criteria did not limit the location, age group, or timeframe of
studies because I wanted to combat the effects of groupthink and goal conflict by
integrating quantitative studies from a very diverse dataset to truly arrive at a consensus
of the broad literature available on the subject.
2. Selection of Studies
The starting point for selecting items was my knowledge of existing literature and
conversations with experts and colleagues in various fields. Additionally, I utilized
online databases, specifically Web of Science, and inspected the bibliographies and
reference lists of existing meta-analyses. My final list of analyzed sources was compiled
mostly from the reference lists of existing meta-analyses exploring similar topics as mine
aimed to explore. The reasoning behind this was two fold. First, without an inclusion
criteria filter to screen for quality in the studies, I operated under the assumption that
studies that were included in other meta-analyses (of which, all utilized both
abstract/database screening software and large teams of reviewers and coders) were
deemed by those researchers to be of quality and, therefore, were of a standard of quality
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that could be included in my analysis. Second, without advanced database screening
software, utilizing smaller collections of pertinent studies was beneficial in the issue of
practicality.
While my inclusion criteria are incredibly simple and would seem to open the
floodgates of allowing studies to be included, I also utilized soft-screening practices
throughout my search to determine if a study was eligible. Upon determining an existing
meta-analysis was examining a topic tantamount to mine, I screened its list of analyzed
sources to ensure that the studies included were quantitative outcome studies and fit the
scope of my research question. If they did not, they were excluded. Additionally, the
studies that seemingly fit my inclusion criteria were screened for moral and ethical
legitimacy, as well as for general quality and a lack of questionable methods. While
these soft screening measures were rudimentary, they allowed for a second line of
defense in preventing poor studies from being included, similar to when more complex
meta-analyses use teams of reviewers and coders to determine eligibility of studies
identified by the abstract-screening software.
3. Review and Coding
When it came to reviewing and coding the studies, it was imperative that I
maintain the initially determined scope of my project. In reviewing the studies, it became
increasingly apparent that there are a multitude of approaches, utilizing different drugs,
dosages, time frames, maintenance schedules, administration procedures, environments,
requirements of the addicts, and costs, as well as other factors. Exploring each of these
details and the efficacy of each variable is beyond the scope of my project, mainly
because the review of existing literature found that maintenance as a whole works, and
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the lack of implementation lies in these smaller details of treatment, on which policy
makers do not agree. It is important to note that, because of this, my meta-analysis does
not discriminate between variation on these details, and merely classifies the study as
maintenance or not maintenance. Therefore, it will not be able to discern between each
variation of maintenance treatment in terms of efficacy.
Upon compilation of the studies to be analyzed, the resulting dataset included 100
studies. Of these 100 studies, four were supply or demand reduction and 96 were harm
reduction. Of those 96 harm reduction studies, 12 were classified as not maintenance and
84 were classified as maintenance. Additionally, of the 100 studies total, 80 were
deemed to have worked and 20 were deemed to have not worked.
Once the initial list was compiled, coding began. To code the studies, I identified
general definitions or criteria for the categories into which I sorted the studies. First,
each study was given a unique identification number from 1 to 100. From there, each
study was classified as Harm-Reduction or Not Harm-Reduction (and therefore Supplyor Demand- Reduction), receiving either a 1 or 0 respectively. A very basic definition
was used to classify the overreaching approach. If the study’s primary method of
treatment, intervention, or technique under study predominantly aimed to reduce the
harm associated with heroin use (regardless of if the harm reduction was geared toward
the user/addict or the community/society at large), it was classified as harm reduction.
Similarly, if the study’s primary method of treatment, intervention, or technique under
study predominantly aimed to reduce the supply or demand of heroin in an environment
(community, society, state, prison setting, etc.), it was classified as supply- or demandreduction.
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The next step of coding was to determine the harm-reduction approach as being
maintenance or not maintenance, being coded as 1 or 0 respectively. Of note, is that
those studies that were classified as supply- or demand- reduction were automatically
coded as a 0 at this stage because a supply- or demand- reduction strategy is, of its own
nature, not maintenance. To classify a study as maintenance, it had to meet the following
criteria: 1, participants in the study were given a drug in order to substitute for or control
their heroin use; 2, the drug was given at a specific dosage at specific intervals, and these
dosages and intervals were permitted to vary over the course of treatment; 3, the drug was
given under the assumption it would reduce the harm associated with non-managed drug
use and/or to maintain the participants’ quality of life; and 4, the treatment procedure was
not required to aim at reducing the amount of substitution drug over time to reach
abstinence, but it could be an included treatment goal.
The final step of coding was to determine if the study worked or did not work.
While “worked” and “did not work” are very vague terms, dealing with such a variety of
study types and a variety of outcomes meant that setting a more stringent term or
classification would be impractical and burdensome. Because each field, approach, and
study could have different goals, discerning one specific goal by which to judge such a
variety of studies did not seem realistic, especially because I was dealing with a very
comprehensive and broad collection of studies. To classify a study as having worked or
not worked, I examined three aspects of the study. First, I examined the conclusion and
results sections of each study to determine the goal of the study as well as the outcome. I
specifically looked for statements indicating the success of the treatment, approach, or
technique under study based on its specific goals. Second, I examined comparative
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statements of success. In some studies, a variety of maintenance approaches or a variety
of supply- or demand- reduction strategies were compared. In those cases, I examined
the comparative success of each strategy or variation and looked for statements indicating
their relative success to each other and other strategies. Third, I examined each study
under a lens of discretion, where I used logic, reason, and rationale to determine whether
not only the authors determined the approach to work or not work, but also whether I
determined the approach to have worked in the context of the study as well. Of note, is
that some studies were excluded in this step of coding if the study was ambiguous in
results or if it was equivocal whether the approach “worked” or “did not work”.
Once the coding was completed, several trends became apparent. One of which,
the most apparent and the most worrisome, was that the studies were predominantly
coded as Harm Reduction-Maintenance-Worked. While this is troubling, the Chi-Square
analysis determined that the variance was still enough to draw substantive conclusions
through statistical significance. Additionally, the cross tabulation table indicates that for
both supply- and demand- reduction approaches and harm-reduction approaches that
were not maintenance, more did not work and less did work than if there was no
relationship between the type of study and its success. For harm-reduction-maintenance
approaches, less did not work and more did work than would have if there was no
relationship. The p-value also indicates that the difference between the two is large
enough not to be due simply to random error.
4. Chi-Square Analysis
Once the studies were identified and coded, they were analyzed using Chi-Square
analysis. This type of analysis was chosen to compare two nominal level variables (the
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type of approach and whether it worked or did not) and determine if they are reliably
related to or dependent on each other. Because I needed to compare across only two
coding categories rather than three, I introduced a breaking variable, combining the first
two variables- Supply- or Demand- Reduction versus Harm-Reduction and Maintenance
versus Not Maintenance. Therefore, studies that were Supply- or Demand- Reduction
(and therefore not maintenance) were coded 0, studies that were Harm-Reduction and not
maintenance were coded 1, and studies that were Harm-Reduction and maintenance were
coded 2.
Chi Square tests do have some limitations, however, in that it cannot discern the
size, strength, or direction of the relationship between two variables, and can instead only
determine if the variables are independent of each other or related in some way. Because
of this limitation, directional tests were also utilized, including Cramer’s V.

Issues
While the Chi Square test was used to determine the presence of a relationship
between the type of approach used and the outcome of the study, and therefore to
understand the consensus found in the literature regarding effective approaches to heroin
use and abuse, understanding the reasons for the lack of implementation despite the
consensus is a bit more complicated. Overall, this lack of implementation lies in the
issues plaguing the implementation of policy in response to the heroin epidemic. In the
case of heroin, the main issue is discrepancies between fields affected by and involved in
the heroin problem, including but not limited to the criminal justice, medical, legislative,
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political, and economic fields. These differences have their roots in group think and goal
conflict, both of which exacerbate the misalignment between fields, making reaching a
policy consensus nearly impossible.

Groupthink
The first issue from which the misalignment arises is group think. First presented
as a theory in 1971 by Irving Janis, groupthink is “the mode of thinking that persons
engage in when concurrence-seeking becomes so dominant in a cohesive ingroup that it
tends to override realistic appraisal of alternative courses of action” (Janis 1971, 84). One
of the most common norms in the presence of group think is upholding loyalty to the
group by maintain the policies to which the group has already committed, even when
those policies have unintended consequences or are working out badly. In group
decision-making settings, members of the ingroup adopt soft-line criticism of their peers,
leaders, and themselves, and conflict rarely occurs in the decision making process. This
is not to say, however, that all groups will succumb to the perils of groupthink in their
decision making, but rather that any advantages of group decision making are often
outweighed due to the psychological pressures of cohesion that arise when members of
the ingroup work closely, share values, and face a crisis situation that stresses the normal
group decision-making dynamic (Janis 1971).
Janis also proposes his main principle of groupthink, which, based on Parkinson’s
Law, states that, “The more amiability and espirit de corps there is among the members
of a policy making ingroup, the greater the danger that independent critical thinking will
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be replaced by groupthink, which is likely to result in irrational and dehumanizing actions
directed against outgroups” (Janis 1971, 85).
Before considering the consequences of groupthink, both as proposed by Janis
and as evidenced in dealing with the heroin epidemic, it is also important to note how
groupthink is present in the policy-making process in regards to heroin. To begin, the
most typical norm of groupthink is “sticking with the policies to which the group has
already committed itself, even when those policies are obviously working out badly and
have unintended consequences…” (Janis 1071, 84). This is evidenced by not just each
field involved in the heroin epidemic, but by the larger American attitude toward dealing
with drugs as well. When the “War on Drugs” began, it became the All-American cause
to eradicate drug use with a punitive and legislative approach. The group most involved
was the bureaucracy, encompassing each and every aspect of policy and every field
involved- medical, criminal justice, political, and others, though the main source of
groupthink was law enforcement. Law enforcement thinks of all the problems it
addresses, including drugs, as law enforcement problems and, since the federal
government is typically stronger on law enforcement than health, the main manifestation
of groupthink was demonstrated in the policy-making process when loyalty to the “War
on Drugs” overshadowed the facts, when they became apparent, that the punitive policies
were having negative effects on the criminal justice system, social dynamic, and
economy.
Within each field involved in the policy making process and the heroin epidemic,
however, groupthink is also apparent. This is due to the strong bond between members
of each field; for instance, the bond within groups and associations of medical
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professionals, lawyers, judges, police, politicians, pharmaceutical companies, social
workers, and other ingroups of parties involved in and affected by the epidemic mean
each have a delineated approach toward thinking about and solving the heroin epidemic.
Most notably groupthink can be seen in the treatment camp, mostly advocated by medical
professionals. It is the smaller of the two spheres and as it is up-and coming rather than
previously established, it possesses more of the espirit de corps Janis notes is essential for
groupthink to take hold.

Goal Conflict
In addition to groupthink, the second issue which exacerbates the misalignment
between fields is that of goal conflict. Conflict, in and of itself, is difficult to define, but
within the organizational setting it has its roots in disagreement, contradiction, and
incompatibility. Conflict, itself, should be understood as a dynamic process,
encompassing a sequence of conflict episodes and relationships where a variety of factors
characterize the conditions, affect, perception, and behaviors of the parties involved
(Pondy 1967). Additionally, conflict affects productivity, stability, and adaptability of an
organization in the way the organization reacts to the disturbed equilibrium brought about
by conflict. For goal conflict specifically, the situation is one where desired outcomes
appear to be incompatible. In the case of heroin policy, the basic principles of goal
conflict are maintained and cause serious issues for reaching a policy consensus. In
treating the policy making arena as an organization, these principles can be fleshed out in
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how they directly impact the process of making and implementing policy with which to
deal with the heroin epidemic.
Within organizations, there are three models that have been designed to classify
conflict phenomena. The one most applicable to conflict in making heroin policy is the
bargaining model. This model deals with conflict in competition for scarce resources,
where there is a discrepancy between the demands of the different parties involved and
the available resources. In this case, solving the conflict usually centers around
increasing the available resources or decreasing the demands of the parties involved. In
these interest-group style conflicts, negotiation faces the problem of reaching a consensus
while maintaining both flexibility in dealing with the other parties and rigidity in one’s
own demands. Additionally, this bargaining model is similar to the budgeting process,
where it is an incremental process building on the previously established conflicts and
negotiations, but this process faces concealment that attempts to rationalize the decisions
being made rather than exposing the bargaining process.
In making policy to deal with the heroin epidemic, goal conflict often falls into
this bargaining model. There are scarce resources available for combatting heroin use
and addiction, and different fields with different goals are vying for those scarce
resources. The criminal justice system, historically at least, advocated for spending
limited resources on punitive measures, while the political realm advocated for spending
resources on public education campaigns to boost moral and rally societal support around
anti-drug legislation. On the other hand, medical fields advocated, and still are, for harm
reduction programs including needle exchanges on the public health front, public
education, and funding and access for addicts to maintenance programs. Historically, the
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bargaining process was more spread out, with many different fields aiming to achieve
many different goals, but as of late, this bargaining process has converged on
maintenance treatments and harm reduction strategies. This is not to say, however, that
there is not still bargaining and allocation of scarce resources to be done; although the
goals are less different now, the fields are still at odds about the best way to manage the
scarce resources in the most effective and efficient way to achieve their goals.
In considering this model of conflict, it becomes apparent that while there is
conflict between the groups, the conflict lies less in the goals and more in the means of
achieving those goals. Each field’s goal is to solve the problem of heroin use and abuse.
That goal, however, takes many different forms: reducing the public harm, reducing the
harmfulness of engaging in drug use, increasing public awareness and access to
treatment, and, in the past, increasing punitive measures, reducing the supply of the drug,
reducing the demand, and increasing anti-drug and drug-control legislation. Today,
however, literature in all fields seems to agree on a broad idea that harm reduction
through maintenance treatment works. With the unified goal of solving the problem, and
the consensus that maintenance treatment works, why is conflict still a problem? L. J.
Bourgeois III puts it this way: “Agreement on goals without agreement on means
correlates with poor performance.”

Means Misalignment
After exploring both groupthink and goal conflict more in depth, it becomes
apparent that the general misalignment cited as influencing the policy making process in
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dealing with the problem of heroin is more specifically “means misalignment”, where the
fields are unable to agree on the means by which to achieve the goal of implementing
policy that supports the consensus that maintenance treatment works as an approach to
the heroin epidemic. Means misalignment is wherein the problem lies in implementing
heroin policy. Because the fields do not agree on the details of the policies, the means by
which the general idea behind the policy should be realized, a policy consensus cannot be
reached. This, of course, is in spite of the mounting evidence and full bodied literature
discussing the merits of maintenance treatments, which exhibits the goal consensus in
regard to heroin policy. Having goal consensus, however, is not sufficient for achieving
policy consensus, because the details of implementation must be agreed upon as well.
Bourgeois, cited above, acknowledges that human actors are expected to be
teleological and goal directed, and that the Western world agrees that the rational way to
make a decision is to determine a goal, then identify the means to attain that goal. In his
study, however, he compares the strategic planning school and the incremental school to
determine how decision making should proceed. In the strategic planning school,
decision makers define goals and objectives, form a list of policy alternatives or means,
assess the probabilities of consequences for each alternative, make a choice, and then
take action on those choices.

This school of strategic planning is the traditional and

normative approach to decision theory, and it is typically accepted that there should be
agreement on policy makers on the goal priorities of the policy. In the incremental
school, policy makers look for alternatives until an acceptable solution is found, and the
goals and means are adjusted while alternatives are evaluated based on analysis of
incremental differences from the status quo. Rather than goals being established before
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evaluating alternatives, the goals and means adjust based on what the current situation
dictates.
Overall, this presents a juxtaposition of the two orientations- one of goal
consensus, where agreeing on the goal will lead to success, and one of means consensus,
where agreeing on the means and not the goal is the key to success. Bourgeois ultimately
determines in his comparative study that lack of consensus on means is more troublesome
to successful policy implementation than disagreement on the ends (goals), and therein
lies the issue for successful implementation of heroin policy. Under the assumption that
the variations in agreement, whether on goals or means, cause differences in
performance, or successful implementation of policy in this case, Bourgeois study
supports the idea that the best policy outcomes will arise when the policy making groups
agree on means and a narrow range of operable goals, and disagree on the less tangible
goals. In the case of heroin policy, the means would be the specific policy or policies to
be implemented. The narrow range of operable goals would include goals such as
increasing access to maintenance treatment programs by increasing funding, increasing
the availability of substitution drugs for addicts, or reducing restrictions on clinicians
administering the substitution therapies. The less tangible goals would include ideals
such as fixing the heroin epidemic, reducing the number of overdose deaths, or
implementing maintenance treatment policy.
Similarly, his results support the notions that: 1, consensus on means always
yields higher performance than disagreement on means; 2, allowing disagreement on less
tangible goals tends to be associated with better performance; and 3, the worst policy
outcomes result when goals agreement occurs with means disagreement. In this way,
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disagreement on the means may hurt the implementation of policy because the strategies
of the different groups involved clash, “causing muddled and internally inconsistent or
incomplete strategies” (Bourgeois 1980, 244). The situation with heroin policy in
America is accurately described by the third notion- there is definite goals agreement on
all the fields and parties involved in the policy-making arena, where they all agree that
the epidemic would be best resolved through implementation of policy focused on harmreduction maintenance treatment, but the disagreement arises when considering the
means by which to implement that policy directive. Between the different dosages, time
frames, environments, administration procedures, costs, and other factors involved in
maintenance treatment, there is much to be decided upon when it comes to establishing
the means to reach the goal. Therefore, it is these policy details, the specific means, that
hinder implementation of policy. According to Bourgeois’ typology, reaching a policy
consensus would benefit from the parties involved agreeing on the means by which to
achieve the goal of solving the heroin epidemic, and allowing for disagreement on the
less tangible goals, such as the ideals listed above, would allow for better policy
outcomes as well.
Means misalignment is exacerbated by both groupthink and goal conflict.
Groupthink, as an issue, affects means misalignment in the group’s perspective on the
means by which the goal should be achieved. As described, because of groupthink, each
field is cemented in its own set of means geared toward the fields tangible subset of goals
that fall within the widely agreed-upon goal to implement policy that supports
maintenance treatment to deal with the heroin epidemic. Groupthink is what keeps the
fields from negotiating on the details of implementing policy, the means. Each field has
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a subset of goals and its own “best” way of achieving these goals within the larger
framework of the consensus exhibited by the literature. Because the fields are
approaching the issue as an ingroup under the influence of groupthink, they do not
approach policy making unencumbered by their on preconceived perspectives. Rather,
they approach them with reduced realistic evaluation of the alternative sets of means
being presented and are often irrational in their avoidance of information that contradicts
their set point of view, which makes negotiation between the fields nearly impossible.
Goal conflict, the second issue exacerbating means misalignment, has a more
straightforward relationship with means misalignment. It is not focused on the broad goal
that the fields agree on- that of implementing maintenance treatment policy. The goal
conflict in this situation is instead on what Bourgeois describes as the tangible goals, the
subset of more specific and concrete goals that each field diverges on. Because of this
divergence on exactly what the goal is under the umbrella of solving the problem of drug
use and abuse, the fields have different means for achieving those goals, and without
agreement on the means, a policy consensus will not be reached.
In answering the question of why, in the face of mounting evidence in favor of
maintenance treatment approaches to heroin, there is a lack of policy consensus and
implementation, exploring the root issues of groupthink and goal conflict, as well as the
ultimate means misalignment between fields, goes far to address the lacking
implementation of policy in response to the heroin epidemic. It is not the broad goal of
eradicating the problem of heroin use and abuse that limits policy consensus. Instead, it
is the misalignment on the means by which the policy goal should be achieved, the details
of the policy’s execution, that hinders implementation. With groupthink limiting the
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capacity of the fields to attempt negotiations due to the fields being unwilling to
relinquish commitment to their unique point of view and goal conflict between the fields’
specific subsets of goals influencing the different means by which the fields favor
achieving those goals, means misalignment is at the heart of lacking policy consensus and
implementation in solving the heroin epidemic.

Methodological Concerns
As with any study, a variety of methodological concerns and issues of data
collection and analysis were found throughout the project. Many of these concerns have
their roots in the issues cited above, and while some were addressed as best as possible
given the circumstances of the study and available resources, some concerns were had
due to the nature of this specific study and merit heeding. Along with issues associated
with the type of study being a meta-analysis, this specific study had four main issues that
were more specific to the circumstances of this particular project: lacking variation in
data, drop out rates, selection bias, and concerns of special populations and ethics.
The first set of issues and limitations arises simply from the nature of the metaanalysis. Although meta-analyses are used in many disciplines to incorporate findings
from many studies, the meta-analysis itself remains controversial due to the use of
dissimilar studies, publication bias, and inclusion of poor quality studies. In many metaanalyses, the researchers define the subject so broadly that studies are often compiled into
a data set with disregard for important differences between the studies that would warrant
them incomparable. In this meta-analysis, it is clear that the subject is defined very
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broadly, but this broadness plays into the broad scope of the research question itselfwhat is the consensus of literature on combatting the heroin epidemic? Without a team of
researchers to peruse abstracts or abstract-scanning software, however, it is quite possible
that some very distinct studies were included in the data set, especially because the
inclusion criteria were not overly restrictive. Presumably, the studies themselves are
similar enough to determine an outcome for coding that would not discredit the merit of
this meta-analysis.
Publication bias, which will also be discussed within the issues associated with
this specific meta-analysis, arises due to the fact there exists a bias toward publishing
studies with statistically significant results, leaving many studies with insignificant or
negative results unpublished. While a non-result or weak result are still results, they are
not the kind that get published. This likely leads to a biased sample of studies and
overestimation of the effects of what is being studied. Once again, lacking resources
meant I was unable to identify or include unpublished studies, which limits how far this
project could go in mitigating the effects of publication bias, but, based on the
circumstances of data collection and goals of this project, the methods suffice.
A final limitation of general use of a meta-analysis is that of including poor
quality studies. While the inclusion criteria for this project did not include any formal
methodological quality controls, soft screening practices for each study were utilized to
ensure that the studies included in this analysis possessed a basic level of methodological
merit. It is quite possible that studies that were not methodologically sound were
included in this analysis, but no study is completely free from weaknesses in
methodology and judging the strength of each study would have been cumbersome and
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may have introduced bias from the criteria assessing quality. It is assumed, however, that
the studies included in this analysis were reviewed by their respective publishers with
care enough that any study prompting serious concern would not have been published in
the first place, and therefore would have been excluded preveniently.
The second set of issues are related more to the specifics of this project than
general limitations of conducting a meta-analysis. First, the data set was lacking in
variation. 96% of the studies included in the data set were harm reduction, and 87.5% of
those harm reduction studies were classified as maintenance studies. Clearly, the
majority of the studies included were harm reduction maintenance studies and, further,
86.9% of these studies were classified as having worked. This bias in the literature could
be due to a few things. For one, groupthink, as explored earlier, discourages novel
information from being presented and discussed within fields. Because of this, if the
group assumes the majority convention that harm reduction, maintenance treatments
work, that is the literature that will be accepted, discussed, and presented as fact, simply
because the group does not acknowledge conflicting information. Additionally,
publication bias comes into play here just as it does with general meta-analyses. I used
the available literature to compile my data set, and the available literature is what was
able to get published. In academia, those studies that do not work do not get published.
This introduces a bias towards studies working, which means that when publication bias
is combined with groupthink bias, this meta analysis was swayed toward overestimating
the success of the approach favored under groupthink.
The second issue unique to this study is that of high drop out rates. When
investigating the literature and, more specifically, the studies included in this dataset, a
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recurring methodological concern was drop out rates. Many of the studies were of a
small-n to begin with, so having even only a few subjects drop out of the study meant the
validity of the study could be called into question, simply because the sample may have
lost representativeness. When considering the subject matter of this project and the
studies on which it is based, it becomes a question of if the approach deemed to be “most
successful”, in this case maintenance treatments, is only successful because those for
whom it is not successful drop out of the study, leaving only subjects for whom the
approach achieved the goal in the end. This could easily inflate the successful outcome of
studies. Moreover, when it comes to drug use and approaches, if the approach is not
working (whether this sense of success is felt by the subject/patient or the researcher) the
subject will either drop out by their own choice because continuing with an ineffective
approach is irrational or drop out due to mortality, the drug use or comorbidity taking
their life. Therefore, those for whom the approach did not work were not present at the
conclusion of the study for their negative results to be included. If only successful
participants remain at the end, the results will be skewed toward success.
Third, selection bias was an additional limitation of this project. Without abstract
screening software or even a second set of eyes to review or challenge my own coding, it
is quite possible that some of the studies included should not have been or, when coded,
were coded incorrectly. When dealing with such an abstract subject, however, there is
bound to be some discretionary error. The preconceived notions with which I was
evaluating these studies are different than those of other researchers, and are additionally
different than the biases applied by a computer program. Because of this, selection bias
and natural human error are concerns to be had in evaluating the methods of this study.
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The fourth and final limitation of this project is that of dealing with ethics and
concerns in dealing with special populations. The nature of heroin use is that it is not
only illegal, but also socially condemned and a sensitive topic of discussion. Within the
history of heroin, treatment approaches were often experimented with in a prison setting,
and while there are now guiding ethical standards that deem much of that
experimentation taboo, utilizing special populations of prisoners or corrections
populations in drug use studies is not uncommon. This is mostly due to the fact that it is
difficult to find heroin users who are willing to step forward, admit their illicit behaviors,
and submit themselves to research. Utilizing corrections populations means that they
have already been convicted, their drug use being known, and that incentives can be
offered to encourage participation.
This, of course, lends itself to ethical concerns of coercion, but also to concerns of
selection bias, sampling bias, and skewing of results. With ulterior motives for
participation coupled with motives for showing the approach to be successful, the results
of studies using corrections populations lack validity. There is also a question of the
representativeness of the sample being used because there may be other variables linking
the type of prisoner that self selects into participating or motivations of prisoners to
success in different approaches. Related to this idea is motivation, on which few studies
report data. Motivation for not only participating but also being successful in the
treatment goals may be important in explaining the differences between subjects and their
success. While studies must go through Institutional Review Boards and are reviewed
before publication for being methodologically sound, it is still possible that motivation
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and sampling were prodigious issues in the studies utilized in this project’s data set, and
therefore influenced this project as well.
Keeping in mind these issues and limitations of not only general meta-analyses,
but also of this specific project, it is notable that no study is perfect in its methods. Metaanalyses themselves, however, are a secondary analysis technique, and are therefore
subject to the weaknesses of the studies which they employ. The generalizability of
meta-analyses is limited to the state and scope of the literature on which it is founded. In
this case, the research question examined the consensus of the literature on approaches to
the heroin epidemic, so using the available literature and relying on its characteristics is
acceptable, but any results or conclusions of this analysis should still be understood
within the context of the issues presented here.

Analysis
This project is a meta-analysis of 100 quantitative studies regarding approaches to
heroin addiction and abuse with the goal of addressing the question, “What is the
consensus of the literature in regard to heroin policy?” Besides the standard descriptive
statistics, cross tabulation tables were used to explore any patterns in the literature and
Pearson’s Chi Square and Craver’s V statistics were also used to quantify the relationship
between variables.
To begin, summary statistics were used to get a feel for the distribution of the
data, which can be seen in Table 1. Each observation was evaluated on three
dichotomous variables: as a harm reduction approach, as a maintenance approach, and if
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it worked, where positive answers to these variables were given a 1 and negative answers
were given a 0. Additionally, a breaking variable was created using the data from the
first two variables that coded each observation on a scale of 0 to 2 based on the amount of
maintenance involvement. Those that received zeroes across the board were coded zero
on this breaking variable as not harm reduction and therefore not maintenance. Those
receiving a one were harm reduction, but not maintenance and those receiving a two were
harm reduction and maintenance.

Variable
Harm Reduction
Maintenance
Worked
Treatment (0-2)

Table 1: Summary Statistics of Each Variable
n=
Mean
Standard Deviation
100
.96
.197
100
.84
.368
100
.8
.402
100
1.8
.492

Min
0
0
0
0

Max
1
1
1
2

Although the statistics indicate that the data was skewed toward maintenance approaches,
this does not necessarily denote a problem with the data or its collection. Rather, it
indicates that there is a gap in the literature surrounding supply reduction approaches.

The cross-tabulation table, Table 2, explains much of the story to be told by the
literature by allowing for the examination of if there is a relationship between variables,
or if one is dependent on (or if not, independent of) the other. It displays the observed
and expected frequencies of each type of case, comparing if the variable worked (or did
not work) with the type of approach used (on the ordinal breaking variable) where the
first row shows studies whose approach of interest did not work, and the second shows
those that did. The rows indicated by “expected” contain the number of cases that should
fall into that category based on the sample if there were no relationship between the type
of approach and if it worked. The rows indicated by “observed” contain the number of
cases from the sample that actually fell into the category.
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For supply reduction, more did not work and less did work than would be
expected if there was no relationship between the approach and its success. For harm
reduction approaches that were not maintenance approaches, more did not work and less
did work than could be expected, similar to the supply reduction category. For harm
reduction approaches that were maintenance, less did not work and more did work than
could be expected if there existed no relationship between the approach and its success.
Overall, the evidence in these compared frequencies displays a relationship between the
type of approach and the outcome of the study.
Table 2: Cross Tabulation Table Comparing Outcome of the Study and the
Approach Utilized
Supply
Harm Reduction Harm Reduction
Outcome
Total
Reduction
Not Maintenance
Maintenance
0 – Didn’t
4
5
11
20
Work
Observed
0.8
2.4
16.8
20
Expected
1 – Worked
Observed
0
7
73
80
Expected
3.2
9.6
67.2
80
4
12
84
100
Total

X2 = 22.0238, p = < .001
Cramer’s V = .4693, p = <.001
This table displays a potential relationship between these two variables that is confirmed
by both the Chi Square and Cramer’s V statistic.

While the cross tabulation table alone indicates a potential relationship between
the two variables, where the approach used in the study is related to the outcome of the
study, statistical tests can provide an opportunity for inferences to be made about the
population. Running a Pearson’s Chi Square Test for Independence yielded a X2 statistic
of 22.0238 (p-value < .001). While this number does not indicate strength or direction of
the relationship, nor that one variable causes the variation in the other, it does allow for
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the conclusion that there is a significant relationship between the two variables in the
literature.
A Cramer’s V Measure of Association was also run to determine the strength of
the relationship between approach and outcome, yielding a result of .4693 (p-value <
.001). This indicates a moderately strong, and nearly very strong, relationship between
what approach is used and the outcome of the approach, where the more maintenancefocused an approach is, the more likely it is to work.
Upon evaluation of the cross tabulation table and the Chi Squared and Cramer’s V
statistics, it can be concluded that there is a relationship between the approach used and
the outcome of using that approach, where maintenance approaches are more likely to
work than harm reduction strategies that are not maintenance and, subsequently, supply
reduction strategies. Based on this assessment, where the units of analysis are pieces of
literature regarding approaches to heroin addiction and abuse, the consensus of literature
can be interpreted to be that maintenance approaches work in addressing the problem of
heroin.

Discussion
Statistical analysis on its own only tells part of the story. What are the
implications of the results? The analysis confirmed that there is a relationship between
the approach used and the outcome of using that approach, where the more maintenancefocused approaches are shown to be the most effective compared to other harm-reduction
and supply- and demand- reduction strategies. In this way, the literature has an
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established consensus that maintenance treatments work in addressing the problem of
heroin, but understanding and applying that consensus must be considered in light of
caveats discussed regarding data collection.
The first concern is of the lack variation in the data. There is a gap in the
literature, as evidenced by the lack of criminal justice studies focusing on supply and
demand reduction strategies, that may be brought on by groupthink, where information
that contradicts the ingroup’s accepted thought pattern is neither presented nor discussed.
Similarly, the lack of criminal justice research on the topic could be due to ethical
concerns in dealing with the special population of prisoners. That subgroup of the
population is not easy to study due to issues of coercion and bias, and studies that are
geared toward studying prison populations are not generalizable to the public, which
limits the conclusions that can be drawn based on criminal justice research of this type
and further makes publication of such studies difficult.
The second concern is the issue of high drop out rates. The recurring
methodological concern of dropout rates in the studies used in this analysis indicates that
saying “maintenance works” may not divulge the entire picture. Rather, a more accurate
interpretation of the results of the analysis in light of the dropout rates is that maintenance
treatments act as a screening mechanism. Because those for whom maintenance
treatments do not work typically drop out of the study or are excluded in other ways
(death, for example), the subjects left at the end of the study are those for whom the
treatment worked, inflating the success of the approach. In this way, it becomes apparent
that maintenance approaches, arguably more involved than other approaches, require a
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certain motivation for success that the other strategies do not, meaning that maintenance
treatments work for those who want them to work.
Even with these concerns in mind, the consensus of the literature was confirmed,
and the question still remains as to why policy is not being implemented in line with what
the literature supports. In looking back at the history of heroin, part of this lack of policy
may lie in the methods used over time in dealing with addiction. The effects of the
methods used can be seen in the dichotomy between the European, specifically British,
approach and the American approach. On the one hand, England has approached
addiction through treatment, with a uniquely medical perspective, focusing on Harm
Reduction on the treatment side with emphasis on the addicted individual. On the other
hand, the United States approached addiction with an emphasis on punitive and
prohibitive methods, allowing the criminal justice system and crime-control perspectives
to lead the charge with a focus on supply and demand reduction through legislative
action. This focus meant the complex legislative process hindered implementation of
effective policy because, rather than a unified goal of treatment, the country was tasked
with integrating the goals of the many fields involved into a cohesive policy, which has
been proven to be nearly impossible.
That is where this analysis comes in; the consensus has been reached in the
literature that maintenance works, but it is the details of implementing the maintenance
treatment programs that cause the disagreement. Policy implementation has been
hindered by both goal conflict and group think, both of which exacerbate the means
misalignment between fields and make reaching a consensus on the appropriate policy
difficult. All the parties involved recognize that there is an issue that can be resolved by
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maintenance treatments, and this is demonstrated by the analysis in this project.
However, the fields do not agree on the details of the policy, the best way to achieve
success with maintenance treatments. It is not the goal of eliminating heroin use and
abuse that limits policy, rather it is the misalignment on the means by which the policy
goal should be achieved, the details, that hinder implementation. History is history,
however, and America has faced, and will continue to face, many difficulties in
implementing policy to deal with the heroin epidemic successfully, but that is not to say
that a solution is impossible.
In light of the issues of this study and thoughts regarding why policy is not being
implemented despite the consensus of the literature, the story told by the analysis in this
project is made more complete. By considering the gap in criminal justice literature and
the effects of dropout rates, the conclusion drawn from the analysis is that maintenance
works for those who want it to work. Coupled with the idea that it is the details of
implementation that delay policy, rather than the broad consensus that maintenance
approaches are effective in dealing with heroin use and abuse, the United States needs to
address the issue of consensus by not getting caught up in the details and language of the
issue and, instead, focus on broad legislation where the details of implementation can be
worked out based on each community’s unique situation, the demand for services, and in
seeking to use resources in the most effective and efficient manner.
Moving forward, further research should be done to investigate the characteristics
of those individuals for whom maintenance treatments are successful, to determine for
what sub-population of addicts maintenance treatments work the best, and to investigate
if motivation plays a role in the success of both maintenance approaches and other
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approaches to addressing addiction. Additionally, country comparisons to discern
additional ways in which the government systems affect the formulation and
implementation of drug policy and examining the successes of different approaches
internationally could impact the way the United States approaches drug policy
formulation and implementation.

Conclusion
This project aimed to aid legislators by presenting quantitative evidence on what
policies existing literature supports as working in dealing with the problem of heroin use
in order to shift policies to a more effective approach. In doing so, it sought to address
the question of why, in the face of a seemingly present consensus within the literature,
policy is not being implemented. Upon review and coding of 100 quantitative outcome
evaluations of heroin abuse treatment programs or specific techniques, the Chi Square
analysis, associated cross tabulation table, and Cramer’s V Measure of Association
indicated that there is a relationship between the approach used and the outcome of the
approach, where maintenance approaches are more likely to work than harm reduction
strategies and, subsequently, supply reduction strategies.
While there were limitations in the data collection methods used and caveats
including lacking variation in the data and high drop out rates, the results can be
interpreted to show a consensus in literature that maintenance approaches work in
addressing the problem of heroin. With this consensus, it is expected that policy would
be implemented following the literature, but that is not the case. Examining the methods
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used over time in dealing with addiction, along with the presence of goal conflict and
groupthink exacerbating the means misalignment between fields, offers a probable
explanation for the difficulties legislators face in reaching a policy consensus, and
therefore in implementing effective policy. The study concluded that, while the literature
finds consensus on the idea that “maintenance works”, the details of implementation
cause disagreement between fields; overall, maintenance approaches work for those who
want it to work, and policy makers should focus on implementing broad legislation where
the details of implementation can be worked out based on each community’s unique
situation, the demand for services, and in seeking to use resources in the most effective
and efficient manner.
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